Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

NCT00459277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer Pain

Interventions

DRUG: Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)

Sponsor

Archimedes Development Ltd